A growing pharma company with market cap of around 23000, Torrent Pharms is enjoying a veryk comfortable price to earning of 13 with other players suffering from higher PE. Handsome EPS of 104(TTM), makes Torrent one of the company which is highly under priced. Growing reserves with equity cap of 84 crore, it is able to control on its debt to equity ratio (merely 0.84%) with profit generating efficiency level (ROE) of 19%.
An investor friendly company with CRR and DPR in the ratio of 76 : 24.
Buy with conviction for short to med term perspective.